Melita Jung
Corporate Officer/Principal chez TERNS PHARMACEUTICALS, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Melita Jung
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 22/04/2024 | - |
Historique de carrière de Melita Jung
Anciens postes connus de Melita Jung
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2017 | 01/01/2021 |
| ADAMAS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2014 | 01/06/2017 |
Ascendancy Healthcare, Inc.
 Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Ascendancy Healthcare, Inc. engages in the commercialization of pharmaceutical productS. It enables product entry by providing clinical, regulatory and commercial expertise and oversight along with funding. The company was founded by Arthur Joseph Higgins and Sanford S. Zweifach on November 21, 2011 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/04/2012 | 01/05/2014 |
| STRUCTURE THERAPEUTICS INC. | Corporate Officer/Principal | 01/05/2021 | - |
Formation de Melita Jung
| University of California, Berkeley | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Corporate Officer/Principal | 5 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Ascendancy Healthcare, Inc.
Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Ascendancy Healthcare, Inc. engages in the commercialization of pharmaceutical productS. It enables product entry by providing clinical, regulatory and commercial expertise and oversight along with funding. The company was founded by Arthur Joseph Higgins and Sanford S. Zweifach on November 21, 2011 and is headquartered in San Francisco, CA. | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
- Bourse
- Insiders
- Melita Jung
- Expérience
